ABIO [NASD]
ARCA biopharma, Inc.
Index- P/E- EPS (ttm)-1.28 Insider Own17.90% Shs Outstand14.41M Perf Week0.81%
Market Cap36.80M Forward P/E- EPS next Y- Insider Trans39.91% Shs Float14.30M Perf Month6.44%
Income-18.50M PEG- EPS next Q- Inst Own19.70% Short Float1.17% Perf Quarter7.83%
Sales- P/S- EPS this Y32.80% Inst Trans140.72% Short Ratio1.45 Perf Half Y12.22%
Book/sh3.33 P/B0.74 EPS next Y- ROA-32.00% Target Price- Perf Year-28.12%
Cash/sh3.31 P/C0.75 EPS next 5Y- ROE-34.10% 52W Range1.71 - 3.84 Perf YTD15.35%
Dividend- P/FCF- EPS past 5Y46.80% ROI- 52W High-35.42% Beta2.00
Dividend %- Quick Ratio18.60 Sales past 5Y- Gross Margin- 52W Low45.03% ATR0.10
Employees17 Current Ratio18.60 Sales Q/Q- Oper. Margin- RSI (14)58.42 Volatility5.50% 4.08%
OptionableYes Debt/Eq0.00 EPS Q/Q31.60% Profit Margin- Rel Volume0.38 Prev Close2.49
ShortableYes LT Debt/Eq0.00 EarningsMay 02 AMC Payout- Avg Volume116.04K Price2.48
Recom- SMA204.19% SMA505.02% SMA2005.40% Volume43,706 Change-0.40%
Feb-27-18Initiated Ascendiant Capital Markets Buy $2
Oct-09-13Initiated Dawson James Buy $3.75
Jun-21-22 04:05PM  
May-05-22 04:15PM  
May-02-22 04:15PM  
Apr-18-22 04:30PM  
Apr-05-22 01:35AM  
Apr-01-22 07:09AM  
Mar-31-22 04:15PM  
Mar-14-22 04:15PM  
Mar-07-22 04:30PM  
Feb-08-22 04:21AM  
Jan-04-22 08:30AM  
Dec-02-21 08:30AM  
Nov-20-21 07:01AM  
Nov-09-21 04:15PM  
Nov-02-21 04:15PM  
Oct-29-21 07:03AM  
06:26AM  
Oct-28-21 04:30PM  
Sep-16-21 08:30AM  
Aug-16-21 08:05AM  
Aug-12-21 01:15AM  
Aug-09-21 08:00AM  
Aug-04-21 04:15PM  
Jul-28-21 08:00AM  
Jul-13-21 08:00AM  
Jul-09-21 08:00AM  
Jul-08-21 11:20AM  
Jul-07-21 08:00AM  
Jun-23-21 09:35AM  
May-11-21 04:15PM  
May-05-21 04:05PM  
May-03-21 04:30PM  
Mar-18-21 04:30PM  
Feb-13-21 01:09AM  
Dec-15-20 08:30AM  
Dec-09-20 05:40PM  
Nov-23-20 12:28PM  
08:30AM  
Nov-02-20 08:30AM  
Oct-07-20 08:30AM  
Oct-05-20 04:30PM  
Sep-21-20 08:00AM  
Aug-17-20 08:49AM  
Aug-12-20 08:00AM  
Aug-05-20 04:15PM  
Jul-07-20 08:30AM  
Jun-03-20 09:56AM  
09:56AM  
Jun-01-20 08:20AM  
May-29-20 12:24PM  
09:59AM  
May-28-20 04:19PM  
12:14PM  
10:27AM  
08:00AM  
May-07-20 08:30AM  
May-06-20 04:30PM  
Feb-18-20 04:30PM  
Feb-01-20 08:31AM  
Nov-06-19 04:10PM  
Nov-03-19 08:47AM  
Sep-12-19 08:30AM  
Sep-11-19 08:30AM  
Sep-04-19 01:37PM  
Aug-21-19 09:49AM  
Aug-01-19 04:30PM  
Jun-04-19 07:09AM  
May-13-19 09:00AM  
May-08-19 04:30PM  
May-01-19 08:30AM  
Apr-23-19 08:30AM  
Mar-18-19 08:30AM  
Mar-06-19 08:00AM  
Feb-27-19 04:15PM  
Feb-20-19 07:30AM  
Jan-16-19 08:30AM  
Dec-26-18 11:47AM  
Dec-20-18 04:01PM  
Nov-14-18 04:30PM  
Nov-12-18 08:30AM  
Nov-05-18 08:30AM  
Oct-10-18 04:16PM  
Oct-02-18 08:00AM  
Sep-18-18 08:30AM  
Aug-09-18 04:15PM  
Aug-03-18 09:45AM  
Jul-31-18 12:15PM  
08:30AM  
08:10AM  
Jun-19-18 07:05AM  
May-29-18 08:30AM  
May-11-18 08:20AM  
May-10-18 08:30AM  
07:15AM  
May-08-18 04:15PM  
Apr-23-18 08:30AM  
Apr-03-18 07:20AM  
Mar-22-18 04:30PM  
Feb-27-18 03:00PM  
Feb-26-18 02:18PM  
ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydrochloride), a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with chronic heart failure. ARCA biopharma, Inc. has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial; and research collaboration with Colorado Prevention Center, the University of Colorado's Academic Research Organization to develop and commercialize Gencaro. The company was incorporated in 2004 and is headquartered in Westminster, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Funicular Fund, LPMay 25Buy2.3264,851150,7402,580,452May 25 05:12 PM
Funicular Fund, LPMay 24Buy2.2918,11041,3832,515,601May 25 05:12 PM
Funicular Fund, LPMay 23Buy2.292,3015,2812,497,491May 25 05:12 PM
Funicular Fund, LPMay 19Buy2.25122,495,190May 20 06:01 PM
Funicular Fund, LPMay 18Buy2.3013,07230,1262,495,189May 20 06:01 PM
Funicular Fund, LPMay 16Buy2.3042,91498,6462,482,117May 16 07:31 PM
Funicular Fund, LPMay 13Buy2.2914,00032,1192,439,203May 16 07:31 PM
Funicular Fund, LPMay 12Buy2.2727,92263,3772,425,203May 16 07:31 PM
Funicular Fund, LPMay 11Buy2.2924,59656,2022,397,281May 11 06:38 PM
Funicular Fund, LPMay 10Buy2.2820,97947,9272,372,685May 11 06:38 PM
Funicular Fund, LPMay 09Buy2.2749,221111,7222,351,706May 09 05:44 PM
Funicular Fund, LPMay 06Buy2.2857,998132,3922,302,485May 09 05:44 PM
Funicular Fund, LPMay 05Buy2.2716,90338,4492,244,487May 09 05:44 PM
Funicular Fund, LPMay 02Buy2.311,2592,9152,227,584May 02 07:03 PM
Funicular Fund, LPApr 29Buy2.308,97420,6442,226,325May 02 07:03 PM
Funicular Fund, LPApr 28Buy2.3223,38154,1712,217,351May 02 07:03 PM
Funicular Fund, LPApr 25Buy2.2913,75131,5082,193,970Apr 27 06:33 PM
Funicular Fund, LPApr 18Buy2.319,11921,0802,180,219Apr 20 07:43 PM
Funicular Fund, LPApr 14Buy2.3317,41040,5462,171,100Apr 14 08:04 PM
Funicular Fund, LPApr 12Buy2.3269,398161,1012,153,690Apr 12 07:31 PM
Funicular Fund, LPApr 11Buy2.314,65510,7762,084,292Apr 12 07:31 PM
Funicular Fund, LPApr 08Buy2.3130,66070,8522,079,637Apr 12 07:31 PM
Funicular Fund, LPApr 07Buy2.3227,45063,7062,048,977Apr 07 08:38 PM
Funicular Fund, LPApr 06Buy2.3026,80661,6032,021,527Apr 07 08:38 PM
Funicular Fund, LPApr 05Buy2.3049,728114,4691,994,721Apr 07 08:38 PM
Funicular Fund, LPApr 04Buy2.26122,342276,3091,944,993Apr 04 08:26 PM
Ozeroff Christopher DavidS.V.P., General CounselNov 22Buy2.2650,000113,21050,970Nov 23 04:53 PM